Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary...
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 33 1 58 33 50 00
Fax: 33 1 58 33 50 01
Address:
65, quai Georges Gorse, Boulogne-Billancourt, France
